Recent Finacing
Recent Raise
Biocartis develops and commercializes compact, fully automated molecular diagnostics platforms (Idylla/Apollo) and a portfolio of oncology and multiplex biomarker assays for rapid point-of-care testing.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
